Add Formweb to your mobile device
12/09/21 aa Hydralazine for Hypertension: Comment Update
December 13, 2021
From: "Aaron Atkins" <aaron.atkins@hhsys.org>
To: "Pharmacists" <grp_allpharm@hhsys.org>
Sent: Thursday, December 9, 2021 11:15:48 AM
Subject: Hydralazine for Hypertension: Comment Update
We received a request to update the ‘standard’ hypertension comment on hydrALAZINE orders included in Powerplans due to misinterpretation of the current instructions related to HR < 60 BPM.
Previous Comment: PRN systolic blood pressure greater than 160 mmHg, unrelieved by labetalol (if ordered) or HR < 60 BPM. Not to exceed 5 mg/min.
New Comment: PRN systolic blood pressure greater than 160 mmHg. If labetalol ordered, give hydrALAZINE if labetalol is ineffective OR labetalol is clinically inappropriate (HR < 60 BPM). Not to exceed 5 mg/min.
This was updated on the following Powerplans in Production today:
-ICU Common Concerns
-HOSP Common Concerns
-GENSURG Common Concerns
-ORTHO Joint Multimodal Analgesia and MISC PostOp Orders
The new comment will show for new orders going forward. There is not a need to update this comment on previously placed orders.
Since this a common order/comment for this product, I wanted to make sure all were aware of the modification. Please let me know if you encounter any issues or have any questions. Thank you.